UiPath, Inc.(PATH)Stock Performance & ReturnsNYSE
Returns, drawdowns and benchmark comparison
Peer Comparison
Relative scale, growth, and profitability vs sector peers
| Ticker | Market Cap | P/E Ratio | Revenue Growth | Net Margin | EPS | ROE | Debt/Equity | Dividend Yield | 52W High | 52W Low |
|---|---|---|---|---|---|---|---|---|---|---|
PATH | 6.91 B | 18.93x | 13.40% | 21.03% | $0.70 | 20.03% | 4.09x | 0.00% | $19.84 | $9.20 |
FTNT | 138.75 B | 67.06x | 25.60% | 28.17% | $2.82 | 117.44% | 0.36x | 0.00% | $181.37 | $73.55 |
ZS | 35.35 B | - | 24.90% | -1.89% | -$0.39 | -2.87% | 0.72x | 0.00% | $336.99 | $114.62 |
RBRK | 19.46 B | - | 37.90% | -16.50% | -$1.28 | - | - | 0.00% | $117.05 | $42.25 |
Peer Valuation & Performance Analysis
Peer group analysis for UiPath, Inc. (PATH) compared to its primary competitors (including FTNT, ZS, RBRK) reveals distinct metrics. PATH trades at a valuation premium compared to its competitors, with a P/E ratio of 18.9x versus the peer average of -194.4x (representing a -110% premium). This indicates that the market expects superior growth or commands a quality premium for PATH. In terms of growth, PATH's revenue growth of 13.4% lags behind the peer average of 29.5%, indicating potential market share losses or slower industry adoption. Additionally, it boasts superior profitability with a net margin of 21.0% compared to the peer average of 3.3%, demonstrating strong cost controls and pricing power.
Peer Performance Rankings
Ranking comparison across key performance metrics
P/E Ratio (Lower is Better)
Revenue Growth
Net Profit Margin
Financial Rankings Summary
• PATH ranks #1 in P/E ratio, #4 in revenue growth, and #2 in profit margins
• Average ranking: #2 - 🎯 Top-tier fundamentals relative to peer group
• Rankings based on actual financial data from company reports
Historical Trading Data
Price and volume data with customizable timeframes
Showing 15 of 15 trading sessions from the last 15 days
| Date | Open | High | Low | Close | Volume | Daily Change |
|---|---|---|---|---|---|---|
| 2026-10-08 | $13.08 | $13.38 | $12.96 | $13.25 | 34,325,000 | +1.38% |
| 2026-10-07 | $13.13 | $13.21 | $12.94 | $13.07 | 22,777,500 | -0.23% |
| 2026-10-06 | $13.22 | $13.35 | $12.94 | $13.10 | 18,203,500 | -0.46% |
| 2026-10-05 | $13.12 | $13.25 | $12.81 | $13.16 | 29,536,200 | +0.30% |
| 2026-10-02 | $13.41 | $13.42 | $13.02 | $13.12 | 19,709,700 | -1.50% |
| 2026-10-01 | $13.07 | $13.45 | $12.94 | $13.32 | 42,708,200 | +3.74% |
| 2026-09-30 | $12.32 | $13.00 | $12.32 | $12.84 | 42,518,700 | +4.22% |
| 2026-09-29 | $12.25 | $12.35 | $11.99 | $12.32 | 36,366,700 | +1.07% |
| 2026-09-28 | $11.99 | $12.36 | $11.57 | $12.19 | 49,586,300 | -2.17% |
| 2026-09-25 | $12.60 | $12.81 | $12.36 | $12.46 | 45,670,200 | -1.11% |
| 2026-09-24 | $13.01 | $13.15 | $12.50 | $12.60 | 48,915,700 | -3.37% |
| 2026-09-23 | $13.23 | $13.37 | $12.65 | $13.04 | 54,338,100 | -1.58% |
| 2026-09-22 | $13.94 | $13.94 | $13.19 | $13.25 | 42,782,800 | -2.50% |
| 2026-09-21 | $13.55 | $13.79 | $13.44 | $13.59 | 46,945,000 | +1.49% |
| 2026-09-18 | $13.87 | $13.95 | $13.32 | $13.39 | 38,661,700 | -2.69% |
Explore More Analysis for PATH
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.